Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
May help reduce cravings and overeating Supports healthy body weight management when combined with proper nutrition and exercise Designed to support healthy metabolic function Triple-Action Metabolic Support Unlike traditional GLP-1 therapies that primarily target a single pathway, Retatrutide is being studied for its ability to activate three metabolic receptors: * GLP-1 * GIP * Glucagon Researchers continue to study how activation of these three pathways may influence metabolic processes
In the Phase 2 obesity trial, retatrutide 12 mg produced approximately 24.2% mean weight loss at 48 weeks ( Jastreboff et al., NEJM 2023 ), and the Phase 2 type 2 diabetes trial showed strong HbA1c and weight reductions ( Rosenstock et al., Lancet 2023 )
T.AkhtarK
Safety and Efficacy of Once-Weekly Semaglutide vs Additional Oral Antidiabetic Drugs in Japanese People With Inadequately Controlled Type 2 Diabetes: A Randomized Trial
Optimal needling protocols Needle depth affects results significantly
Asynchronous-only with no phone line
